Akero Therapeutics Inc.

NASDAQ: AKRO · Real-Time Price · USD
54.27
0.33 (0.61%)
At close: Jun 06, 2025, 3:59 PM
54.28
0.02%
After-hours: Jun 06, 2025, 04:58 PM EDT

Akero Therapeutics Statistics

Share Statistics

Akero Therapeutics has 79.72M shares outstanding. The number of shares has increased by 15.14% in one year.

79.72M
15.14%
14.07%
99.99%
n/a
59
n/a

Short Selling Information

The latest short interest is 6.3M, so 7.9% of the outstanding shares have been sold short.

6.3M
7.9%
8.13%
4.73

Valuation Ratios

The PE ratio is -7.41 and the forward PE ratio is -12.11. Akero Therapeutics's PEG ratio is -0.25.

-7.41
-12.11
0
12.7
2.49
-8.12
-0.25
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Akero Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 19.38, with a Debt / Equity ratio of 0.05.

19.38
19.38
0.05
-0.13
-0.16
0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-3,653,043.48
69
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 152.46% in the last 52 weeks. The beta is -0.16, so Akero Therapeutics's price volatility has been lower than the market average.

-0.16
152.46%
42.25
36.17
69.93
1,442,252

Income Statement

n/a
n/a
-285.42M
-252.06M
-285.42M
-256.73M
-3.75
Full Income Statement

Balance Sheet

The company has 340.24M in cash and 36.46M in debt, giving a net cash position of 303.78M.

340.24M
36.46M
303.78M
-826.16M
1.16B
670.71M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -230.11M and capital expenditures 0, giving a free cash flow of -230.11M.

-230.11M
n/a
-230.11M
-3.43
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

AKRO does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AKRO is $76.5, which is 42.1% higher than the current price. The consensus rating is "Strong Buy".

$76.5
42.1%
Strong Buy
8
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

28.93
2